Michael Wagner, Md

This early-stage study tests a new drug called BTX-A51 in 24 people with advanced liposarcoma (a type of cancer in fat cells) that has spread or come back. The main goal is to see if the drug is safe and tolerable at two different doses. Researchers will also check if the drug he…